<?xml version="1.0" encoding="UTF-8"?>
<p>The prevalence of CZS was 2.1% overall, increasing to one in eight among children whose mothers had confirmed infection, and congenital microcephaly was 40-fold higher than the estimated rate of 0.1 per 1000 live-births for this malformation in Spain [
 <xref rid="B24-pathogens-09-00352" ref-type="bibr">24</xref>]. Despite evidence that birth defects, including OPZRO, can be detected regardless of trimester of infection, for the three CZS cases here maternal infection occurred in the first trimester, as reported in other studies [
 <xref rid="B9-pathogens-09-00352" ref-type="bibr">9</xref>,
 <xref rid="B25-pathogens-09-00352" ref-type="bibr">25</xref>,
 <xref rid="B26-pathogens-09-00352" ref-type="bibr">26</xref>]. For one of the three CZS cases, no maternal symptoms related to ZIKV infection were reported.
</p>
